SCHEMBL28268508

SCHEMBL28268508

O=C(OC1CCC1)c1ccc(OC(F)(F)F)cc1

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ STS P08842 4/20 0.56
▸ SMN1; SMN2 Q16637 3/20 0.52
▸ NPC1 O15118 1/20 0.52
▸ HTT P42858 1/20 0.52
▸ RAB9A P51151 1/20 0.52
▸ HSD11B1 P28845 1/20 0.48
▸ LMNA P02545 1/20 0.48
▸ MAPT P10636 1/20 0.48
▸ NPSR1 Q6W5P4 1/20 0.48
▸ EPHX2 P34913 4/20 0.46
▸ EPHX1 P07099 1/20 0.46
▸ FAAH O00519 2/20 0.45
▸ PARP10 Q53GL7 1/20 0.45
▸ KDM2B Q8NHM5 1/20 0.44
▸ SCN1A P35498 1/20 0.44
▸ SCN2A Q99250 1/20 0.44
▸ SCN3A Q9NY46 1/20 0.44
▸ MGLL Q99685 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27776290 0.91 STS (0.50) STSSMN1; SMN2NPC1HTTRAB9A
SCHEMBL8083202 0.90 STS (0.56) STSSMN1; SMN2NPC1HTTRAB9A
SCHEMBL15939439 0.86 STS (0.49) STSSMN1; SMN2NPC1HTTRAB9A
SCHEMBL1976081 0.84 STS (0.62) STSSMN1; SMN2NPC1HTTRAB9A
SCHEMBL23518946 0.84 STS (0.56) STSSMN1; SMN2NPC1HTTRAB9A
SCHEMBL28266819 0.82 TAS1R3 (0.54) HSD11B1MAPTEPHX2EPHX1MGLL
SCHEMBL27519964 0.81 STS (0.55) STSSMN1; SMN2NPC1HTTRAB9A
SCHEMBL28097193 0.81 EPHX2 (0.44) STSSMN1; SMN2NPC1HTTRAB9A
SCHEMBL9541270 0.80 STS (0.59) STSSMN1; SMN2NPC1HTTRAB9A
SCHEMBL29159624 0.79 TAS1R3 (0.57) STSSMN1; SMN2NPC1HTTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109219602-A Modulators of cystic fibrosis transmembrane conductance regulator proteins 艾伯维公司 2019-01-15 — — CN disclosed
Send feedback